Document is current

Any future updates will be listed below

Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction

Crossref DOI link: https://doi.org/10.1007/s40120-021-00280-1

Published Online: 2021-09-13

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark